BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6091222)

  • 61. Diagnostic value of enzyme linked immuno-sorbent assay for cytomegalovirus disease.
    Priya K; Madhavan HN
    J Postgrad Med; 2002; 48(3):176-8; discussion 190. PubMed ID: 12432189
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Evaluation of the ELISA method of detection "anti-cytomegalovirus" antibodies].
    Re MC; Mazzaracchio R
    Quad Sclavo Diagn; 1980 Jun; 16(2):129-33. PubMed ID: 6264533
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prevalence of cytomegalovirus antibodies in Norwegian kidney-transplant recipients and their living donors. A comparative study of two different methods.
    Skar AG; Hoddevik G
    Acta Pathol Microbiol Immunol Scand B; 1984 Feb; 92(1):1-5. PubMed ID: 6324531
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Serological screening for the prevention of transfusion-acquired cytomegalovirus infection.
    Musiani M; Zerbini M; Carpi C; Plazzi M; Sermasi G; Belletti D; Sacchi R
    J Infect; 1984 Sep; 9(2):148-52. PubMed ID: 6094671
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Development of CMV antibody tests and their clinical evaluation.
    Wielaard F; Scherders J; Dagelinckx C; Hooijmans A; Smit-Siebinga CT; Welle F
    Vox Sang; 1986; 51 Suppl 1():31-4. PubMed ID: 3017004
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cytomegalovirus infection in a volunteer blood donor population.
    Kane RC; Rousseau WE; Noble GR; Tegtmeier GE; Wulff H; Herndon HB; Chin TD; Bayer WL
    Infect Immun; 1975 Apr; 11(4):719-23. PubMed ID: 164405
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Cytomegalovirus infection after transplantation. Virological diagnosis, antiviral treatment].
    Freymuth F; Petitjean J; Eugene-Ruelland G; Daon F; Galateau F
    Pathol Biol (Paris); 1993 Oct; 41(8):724-30. PubMed ID: 8290319
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Detection of antibodies to cytomegalovirus by an improved counterimmunoelectrophoretic procedure.
    Tegtmeier GE; Sweet GH; Bayer WL
    J Med Virol; 1982; 10(1):17-24. PubMed ID: 6290599
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparison of immunoblotting with other serological methods and virus isolation for the early detection of primary cytomegalovirus infection in allograft recipients.
    Miller H; McCulloch B; Landini MP; Rossier E
    J Clin Microbiol; 1989 Dec; 27(12):2672-7. PubMed ID: 2556430
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cytomegalovirus antigenic heterogeneity can cause false-negative results in indirect hemagglutination and complement fixation antibody assays.
    Faix RG
    J Clin Microbiol; 1985 Nov; 22(5):768-71. PubMed ID: 2997271
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Experiences with a "rapid test" in detecting antibodies to cytomegalovirus].
    Milbradt H
    Klin Wochenschr; 1989 Aug; 67(16):839-40. PubMed ID: 2552223
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparison of four methods for screening of cytomegalovirus antibodies in normal donors and immunocompromised patients.
    de Ory F; León P; Domingo C; Garcia-Sáiz A; Pérez L; Echevarría JM
    Eur J Clin Microbiol; 1987 Aug; 6(4):402-5. PubMed ID: 2822396
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Production and characterization of monoclonal antibodies specific for a glycosylated polypeptide of human cytomegalovirus.
    Kim KS; Sapienza VJ; Chen CM; Wisniewski K
    J Clin Microbiol; 1983 Aug; 18(2):331-43. PubMed ID: 6194174
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [CMV antibody determination with two enzyme immunoassays in each case].
    Albert S; Sibrowski W; Kühnl P; Knödler B; Seidl S; Böhm BO; Doerr HW
    Beitr Infusionsther; 1990; 26():40-2. PubMed ID: 1703884
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparative activity of immunofluorescent antibody and complement-fixing antibody in cytomegalovirus infection.
    Betts RF; George SD; Rundell RB; Freeman RB; Douglas RG
    J Clin Microbiol; 1976 Aug; 4(2):151-6. PubMed ID: 184108
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A method for coupling cytomegalovirus antigens to aldehyde-fixed erythrocytes for use in passive hemagglutination.
    Ikram H; Prince AM
    J Virol Methods; 1983 Sep; 7(3):127-34. PubMed ID: 6315750
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Functional Properties of Human Cytomegalovirus Hyperimmunoglobulin and Standard Immunoglobulin Preparations.
    Germer M; Herbener P; Schüttrumpf J
    Ann Transplant; 2016 Sep; 21():558-64. PubMed ID: 27595792
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Indirect ultramicroElisa for the detection of total antibodies against cytomegaloviruses in human blood].
    Laferte J; Marrero M; Alvarez M; Jomarron L; Garcia S; Vazquez S; Morier L; Ulacia M; Melchor A
    Rev Inst Med Trop Sao Paulo; 1992; 34(1):43-7. PubMed ID: 1339151
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A one-step enzyme-linked immunosorbent assay to detect anti-CMV antibodies; development and clinical validation.
    Wielaard F; Scherders J; Dagelinckx C; Gausset P
    J Virol Methods; 1987 Aug; 17(1-2):141-8. PubMed ID: 2822750
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Determination of IgA antibodies to human cytomegalovirus by enzyme-linked immunosorbent assay (ELISA).
    Levy E; Sarov I
    J Med Virol; 1980; 6(3):249-57. PubMed ID: 6262458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.